Ionis Pharmaceuticals competitorsClear all

Ionis Pharmaceuticals's top competitors include Reata Pharmaceuticals, Arrowhead Pharmaceuticals, Alnylam Pharmaceuticals and Regulus Therapeutics.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals discovers and develops RNA-targeted therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date
Founding Date
1989
Founding Date
2002
Founding Date
2004
Founding Date
2002
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Carlsbad, US HQ
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Pasadena, US HQ
Madison, US
San Diego, US
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
San Diego, US HQ
Employees
Employees
81711% increase
Employees
22079% increase
Employees
13416% increase
Employees
1,32324% increase
Employees
2462% decrease
Valuation ($)
Valuation ($)
6 b
Valuation ($)
3.5 b
Valuation ($)
6.6 b
Valuation ($)
16.7 b
Valuation ($)
100.1 m
Twitter followers
Twitter followers
3.3 k
Twitter followers
1.1 k
Twitter followers
2.6 k
Twitter followers
13.9 k
Twitter followers
789
Number of tweets (last 30 days)
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
21
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
12.7
Average likes per tweet (last 30 days)
5
Average likes per tweet (last 30 days)
41.9
Average likes per tweet (last 30 days)
10.2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
95%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
300164
Alexa Website Rank
264292
Alexa Website Rank
246863
Alexa Website Rank
365813
Alexa Website Rank
248055
Employee Rating
Employee Rating
3.5
Employee Rating
4.3
Employee Rating
N/A
Employee Rating
4.3
Employee Rating
2.7

Financial

Revenue (est.)
Revenue (est.)
$729.3m (FY, 2020)
Revenue (est.)
$9m (FY, 2020)
Revenue (est.)
$168.8m (FY, 2019)
Revenue (est.)
$492.9m (FY, 2020)
Revenue (est.)
$10m (FY, 2020)
Cost of goods
Cost of goods
$11.9m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$78.1m (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
$717.3m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Gross profit
$414.8m (FY, 2020)
Gross profit
N/A
Net income
Net income
($486.8m) (FY, 2020)
Net income
($247.8m) (FY, 2020)
Net income
$68m (FY, 2019)
Net income
($858.3m) (FY, 2020)
Net income
($15.7m) (FY, 2020)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
240 (FY, 2016)
Patents Issued
359 (FY, 2016)
Patents Issued
N/A
Patents Issued
300 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 201.3m
Total funding raised
$ 468.9m
Total funding raised
$ 147.1m
Total funding raised
$ 1.5b
Total funding raised
$ 10m
For sources of this data, please see the company profile

View company profiles

Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.

View company
Arrowhead Pharmaceuticals
HQ
Pasadena, US
Employees
134↑ 16% increase

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company